Abstract Title:

Dietary apigenin in the prevention of endothelial cell dysfunction.

Abstract Source:

J Cardiovasc Pharmacol. 2019 Oct 7. Epub 2019 Oct 7. PMID: 31517778

Abstract Author(s):

Ned J Lamb, Florence Gizard

Article Affiliation:

Ned J Lamb


The anti-carcinogenic effects of the polyphenol apigenin (4', 5, 7-trihydroxyflavone) have been amply documented and are currently assessed in clinical studies. Potential benefits against other inflammatory diseases, such as atherosclerosis, are also being uncovered. Following their previous work in the field, Yamagata et al., report in the present issue that"Dietary apigenin reduces induction of LOX-1 and NLRP3 expression, leukocyte adhesion and acetylated low density lipoprotein uptake in human endothelial cells exposed to trimethylamine-N-oxide". Here, the context of this molecular study and its potential for future breakthroughs in cardiovascular pharmacology are discussed.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2021 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.